The virulence factors of bordetella pertussis: Talented modulators of host immune response

Archivum Immunologiae et Therapiae Experimentalis

Volumn 61, Issue 6, 2013, Pages 445-457

  Fedele, Giorgio ^a   Bianco, Manuela ^a,b   Ausiello, Clara Maria ^a  

^a ISTITUTO SUPERIORE DI SANITÀ   (Italy)

^b NOVARTIS VACCINES AND DIAGNOSTICS   (Italy)

Author keywords

Airways epithelium; Bordetella pertussis; Cytokines; Dendritic cells; Macrophages; T cell response

Indexed keywords

ADENYLATE CYCLASE TOXIN; BORDETELLA VIRULENCE FACTOR; CYCLOOXYGENASE 2; CYTOTOXIN; FIMBRIA PROTEIN; HEMAGGLUTININ; INTERLEUKIN 10; INTERLEUKIN 12; INTERLEUKIN 12P70; INTERLEUKIN 1ALPHA; INTERLEUKIN 1BETA; INTERLEUKIN 23; INTERLEUKIN 6; INTERLEUKIN 8; INTERSTITIAL COLLAGENASE; LIPOOLIGOSACCHARIDE; PERTACTIN; PERTUSSIS TOXIN; PERTUSSIS VACCINE; TOLL LIKE RECEPTOR 4; TUMOR NECROSIS FACTOR ALPHA;

ADAPTIVE IMMUNITY; ANTIINFLAMMATORY ACTIVITY; BACTERIAL CLEARANCE; BACTERIAL VIRULENCE; BORDETELLA PERTUSSIS; CYTOKINE PRODUCTION; DOWN REGULATION; ENZYME ACTIVITY; HUMAN; IMMUNE RESPONSE; IMMUNOMODULATION; INNATE IMMUNITY; NEUTROPHIL; NONHUMAN; PERIPHERAL BLOOD MONONUCLEAR CELL; PERTUSSIS; RECEPTOR BINDING; REGULATORY T LYMPHOCYTE; REVIEW; T LYMPHOCYTE ACTIVATION; TH1 CELL; TH2 CELL; UPREGULATION;

ANIMALS; BACTERIAL TOXINS; BORDETELLA PERTUSSIS; CELLULAR MICROENVIRONMENT; CHILD; DISEASE MODELS, ANIMAL; HOST-PATHOGEN INTERACTIONS; HUMANS; IMMUNE EVASION; IMMUNITY, INNATE; IMMUNOMODULATION; INFANT; MICE; VIRULENCE FACTORS; WHOOPING COUGH;

EID: 84890442016     PISSN: 0004069X     EISSN: 16614917     Source Type: Journal    
DOI: 10.1007/s00005-013-0242-1     Document Type: Review

References (129)

1. Abramson T, Kedem H, Relman DA (2001) Proinflammatory and proapoptotic activities associated with Bordetella pertussis filamentous hemagglutinin. Infect Immun 69:2650-2658
2. Abramson T, Kedem H, Relman DA (2008) Modulation of the NF-kappaB pathway by Bordetella pertussis filamentous hemagglutinin. PLoS One 3:e3825
3. Acosta-Rodriguez EV, Napolitani G, Lanzavecchia A et al (2007) Interleukins 1beta and 6 but not transforming growth factor-beta are essential for the differentiation of interleukin 17-producing human T helper cells. Nat Immunol 8:942-949
4. Alfano M, Grivel JC, Ghezzi S et al (2005) Pertussis toxin B oligomer dissociates T cell activation and HIV replication in CD4 T cells released from infected lymphoid tissue. AIDS 19:1007-1014
5. Andreasen C, Carbonetti NH (2008) Pertussis toxin inhibits early chemokines production to delay neutrophil recruitment in response to Bordetella pertussis respiratory tract infection in mice. Infect Immun 76:5139-5148
6. Andreasen C, Powell DA, Carbonetti NH (2009) Pertussis toxin stimulates IL-17 production in response to Bordetella pertussis infection in mice. PLoS One 4:e7079
7. Ashworth LA, Irons LI, Dowsett AB (1982) Antigenic relationship between serotype-specific agglutinogen and fimbriae from Bordetella pertussis. Infect Immun 37:1278-1281
8. Ausiello CM, Fedele G, Urbani F et al (2002) Native and genetically inactivated pertussis toxins induce human dendritic cell maturation and synergize with lipopolysaccharide in promoting T helper type 1 responses. J Infect Dis 186:351-360
9. Ausiello CM, Lande R, Urbani F et al (2000) Cell-mediated immunity and antibody response to Bordetella pertussis antigens in children with a history of pertussis infection and in recipients of an acellular pertussis vaccine. J Infect Dis 181:1989-1995
10. Ausiello CM, Urbani F, La Sala A et al (1997) Acellular vaccines induce cell-mediated immunity to Bordetella pertussis antigens in infants undergoing primary vaccination against pertussis. Dev Biol Stand 89:315-320
11. Bache C, Spreitzer I, Becker B et al (2012) Bordetella pertussis toxin does not induce the release of proinflammatory cytokines in human whole blood. Med Microbiol Immunol 201:327-335
12. Bagley KC, Abdelwahab SF, Tuskan RG et al (2002) Pertussis toxin and the adenylate cyclase toxin from Bordetella pertussis activate human monocyte-derived dendritic cells and dominantly inhibit cytokine production through a cAMP-dependent pathway. J Leukoc Biol 72:962-969
13. Bassinet L, Gueirard P, Maitre B et al (2000) Role of adhesins and toxins in invasion of human tracheal epithelial cells by Bordetella pertussis. Infect Immun 68:1934-1941
14. Belcher CE, Drenkow J, Kehoe B et al (2000) The transcriptional responses of respiratory epithelial cells to Bordetella pertussis reveal host-defensive and pathogen counter-defensive strategies. Proc Natl Acad Sci USA 97:13847-13852
15. Belkaid Y, Oldenhove G (2008) Tuning microenvironments: induction of regulatory T cells by dendritic cells. Immunity 29:362-371
16. Berbers GA, de Greeff SC, Mooi FR (2009) Improving pertussis vaccination. Hum Vaccines 5:497-503
17. Bisgard KM, Pascual FB, Ehresmann KR et al (2004) Infant pertussis: who was the source? Pediatr Infect Dis J 23:985-989
18. Boyd AP, Ross PJ, Conroy H et al (2005) Bordetella pertussis adenylate cyclase toxin modulates innate and adaptive immune responses: distinct roles for acylation and enzymatic activity in immunomodulation and cell death. J Immunol 175:730-738
19. Braat H, McGuirk P, Ten Kate FJ et al (2007) Prevention of experimental colitis by parenteral administration of a pathogen-derived immunomodulatory molecule. Gut 56:351-357
20. Brennan MJ, Li ZM, Cowell JL et al (1988) Identification of a 69-kilodalton nonfimbrial protein as an agglutinogen of Bordetella pertussis. Infect Immun 56:3189-3195
21. Carbonetti NH, Artamonova GV, Andreasen C et al (2005) Pertussis toxin and adenylate cyclase toxin provide a one-two punch for establishment of Bordetella pertussis infection of the respiratory tract. Infect Immun 73:2698-2703
22. Carbonetti NH, Artamonova GV, Andreasen C et al (2004) Suppression of serum antibody responses by pertussis toxin after respiratory tract colonization by Bordetella pertussis and identification of an immunodominant lipoprotein. Infect Immun 72:3350-3358
23. Carbonetti NH, Artamonova GV, Mays RM et al (2003) Pertussis toxin plays an early role in respiratory tract colonization by Bordetella pertussis. Infect Immun 71:6358-6366
24. Carbonetti NH, Artamonova GV, Van Rooijen N et al (2007) Pertussis toxin targets airway macrophages to promote Bordetella pertussis infection of the respiratory tract. Infect Immun 75:1713-1720
25. Caroff M, Karibian D, Cavaillon JM et al (2002) Structural and functional analyses of bacterial lipopolysaccharides. Microbes Infect 4:915-926
26. Chaby R, Garcia-Verdugo I, Espinassous Q et al (2005) Interactions between LPS and lung surfactant proteins. J Endotoxin Res 11:181-185
27. Chang CI, Chelliah Y, Borek D et al (2006) Structure of tracheal cytotoxin in complex with a heterodimeric pattern-recognition receptor. Science 311:1761-1764
28. Cherry JD, Heininger U, Richards DM et al (2010) Antibody response patterns to Bordetella pertussis antigens in vaccinated (primed) and unvaccinated (unprimed) young children with pertussis. Clin Vaccine Immunol 17:741-747
29. Cherry JD (2012) Epidemic pertussis in 2012 - the resurgence of a vaccine-preventable disease. N Engl J Med 367:667-785
30. Cheung GY, Kelly SM, Jess TJ et al (2009) Functional and structural studies on different forms of the adenylate cyclase toxin of Bordetella pertussis. Microb Pathog 46:36-42
31. Connelly CE, Sun Y, Carbonetti N (2012) Pertussis toxin exacerbates and prolongs airway inflammation responses during Bordetella pertussis infection. Infect Immun 80:4317-4332
32. Crowcroft NS, Stein C, Duclos P et al (2003) How best to estimate the global burden of pertussis. Lancet Infect Dis 3:413-418
33. Cummings CA, Bootsma HJ, Relman DA et al (2006) Species- and strain-specific control of a complex, flexible regulon by Bordetella BvgAS. J Bacteriol 188:1775-1785
34. Cundell DR, Kanthakumar K, Taylor GW et al (1994) Effect of tracheal cytotoxin from Bordetella pertussis on human neutrophil function in vitro. Infect Immun 62:639-643
35. de Greeff SC, Mooi FR, Westerhof A et al (2010) Pertussis disease burden in the household: how to protect young infants. Clin Infect Dis 50:1339-1345
36. de Melker HE, Versteegh FG, Schellekens JF et al (2006) The incidence of Bordetella pertussis infections estimated in the population from a combination of serological surveys. J Infect 53:106-113
37. Dieterich C, Relman DA (2011) Modulation of the host interferon response and ISGylation pathway by B. pertussis filamentous hemagglutinin. PLoS One 6:e27535
38. + lymphocytes participate in the IFN-γ response to filamentous hemagglutinin from Bordetella pertussis in infants, children, and adults. Clin Dev Immunol 2012:795958
39. Donato GM, Goldsmith CS, Paddock CD et al (2012) Delivery of Bordetella pertussis adenylate cyclase toxin to target cells via outer membrane vesicles. FEBS Lett 586:459-465
40. Dunne A, Ross PJ, Pospisilova E et al (2010) Inflammasome activation by adenylate cyclase toxin directs Th17 responses and protection against Bordetella pertussis. J Immunol 185:1711-1719
41. Elliott E, McIntyre P, Ridley G et al (2004) National study of infants hospitalized with pertussis in the acellular vaccine era. Pediatr Infect Dis J 23:246-252
42. Fedele G, Bianco M, Debrie AS et al (2011) Attenuated Bordetella pertussis vaccine candidate BPZE1 promotes human dendritic cell CCL21-induced migration and drives a Th1/Th17 response. J Immunol 186:5388-5396
43. Fedele G, Celestino I, Spensieri F et al (2007) Lipooligosaccharide from Bordetella pertussis induces mature human monocyte-derived dendritic cells and drives a Th2 biased response. Microbes Infect 9:855-863
44. Fedele G, Nasso M, Spensieri F et al (2008) Lipopolysaccharides from Bordetella pertussis and Bordetella parapertussis differently modulate human dendritic cell functions resulting in divergent prevalence of Th17-polarized responses. J Immunol 181:208-216
45. Fedele G, Spensieri F, Palazzo R et al (2010) Bordetella pertussis commits human dendritic cells to promote a Th1/Th17 response through the activity of adenylate cyclase toxin and MAPK-pathways. PLoS One 5:e8734
46. Fenou PF, Bertout J, Locht C (2010) T- and B-cell-mediated protection induced by novel, live attenuated pertussis vaccine in mice. Cross protection against parapertussis. PLoS One 5:e10178
47. Fernandez-Botran R, Sanders VM, Mosmann TR et al (1988) Lymphokine-mediated regulation of the proliferative response of clones of T helper 1 and T helper 2 cells. J Exp Med 168:543-558
48. Flak TA, Goldman WE (1999) Signalling and cellular specificity of airway nitric oxide production in pertussis. Cell Microbiol 1:51-60
49. Flak TA, Heiss LN, Engle JT et al (2000) Synergistic epithelial responses to endotoxin and a naturally occurring muramyl peptide. Infect Immun 68:1235-1242
50. Gajewski TF, Fitch FW (1988) Anti-proliferative effect of IFN-gamma in immune regulation. I. IFN-gamma inhibits the proliferation of Th2 but not Th1 murine helper T lymphocyte clones. J Immunol 140:4245-4252
51. Geuijen CA, Willems RJ, Hoogerhout P et al (1998) Identification and characterization of heparin binding regions of the Fim2 subunit of Bordetella pertussis. Infect Immun 66:2256-2263
52. Gray MC, Donato GM, Jones FR et al (2004) Newly secreted adenylate cyclase toxin is responsible for intoxication of target cells by Bordetella pertussis. Mol Microbiol 53:1709-1719
53. Gueirard P, Druihle A, Pretolani M et al (1998) Role of adenylate cyclase-hemolysin in alveolar macrophage apoptosis during Bordetella pertussis infection in vivo. Infect Immun 66:1718-1725
54. Guermonprez P, Khelef N, Blouin E et al (2001) The adenylate cyclase toxin of Bordetella pertussis binds to target cells via the alpha(M)beta(2) integrin (CD11b/CD18). J Exp Med 193:1035-1044
55. Gustafsson L, Hessel L, Storsaeter J et al (2006) Long-term follow-up of Swedish children vaccinated with acellular pertussis vaccines at 3, 5, and 12 months of age indicates the need for a booster dose at 5 to 7 years of age. Pediatrics 118:978-984
56. Hallander HO, Gustafsson L, Ljungman M et al (2005) Pertussis antitoxin decay after vaccination with DTPa. Response to a first booster dose 3 1/2-6 1/2 years after the third vaccine dose. Vaccine 23:5359-5364
57. Harrington LE, Mangan PR, Weaver CT (2006) Expanding the effector CD4 T-cell repertoire: the Th17 lineage. Curr Opin Immunol 18:349-356
58. He Q, Mertsola J (2008) Factors contributing to pertussis resurgence. Future Microbiol 3:329-339
59. Henderson MW, Inatsuka CS, Sheets AJ et al (2012) Contribution of Bordetella filamentous hemagglutinin and adenylate cyclase toxin to suppression and evasion of interleukin-17-mediated inflammation. Infect Immun 80:2061-2075
60. Hewlett EL, Donato GM, Gray MC (2006) Macrophage cytotoxicity produced by adenylate cyclase toxin from Bordetella pertussis: more than just making cyclic AMP! Mol Microbiol 59:447-459
61. Hickey FB, Brereton CF, Mills KH (2008) Adenylate cycalse toxin of Bordetella pertussis inhibits TLR-induced IRF-1 and IRF-8 activation and IL-12 production and enhances IL-10 through MAPK activation in dendritic cells. J Leukoc Biol 84:234-243
62. Higgins SC, Jarnicki AG, Lavelle EC et al (2006) TLR4 mediates vaccine-induced protective cellular immunity to Bordetella pertussis: role of IL-17-producing T cells. J Immunol 177:7980-7989
63. Inatsuka CS, Julio SM, Cotter PA (2005) Bordetella filamentous hemagglutinin plays a critical role in immunomodulation, suggesting a mechanism for host specificity. Proc Natl Acad Sci 102:18578-18583
64. Inatsuka CS, Xu Q, Vujkovic-Cvijin I et al (2010) Pertactin is required for Bordetella species to resist neutrophil-mediated clearance. Infect Immun 78:2901-2909
65. Ishibashi Y, Claus S, Relman DA (1994) Bordetella pertussis filamentous hemagglutinin interacts with a leukocyte signal transduction complex and stimulates bacterial adherence to monocyte CR3 (CD11b/CD18). J Exp Med 180:1225-1233
66. Jacob-Dubuisson F, El-Hamel C, Saint N et al (1999) Channel formation by FhaC, the outer membrane protein involved in the secretion of the Bordetella pertussis filamentous hemagglutinin. J Biol Chem 274:37731-37735
67. Jones AM, Boucher PE, Williams CL et al (2005) Role of BvgA phosphorylation and DNA binding affinity in control of Bvg-mediated phenotypic phase transition in Bordetella pertussis. Mol Microbiol 58:700-713
68. Kaneko T, Yano T, Aggarwal K et al (2006) PGRP-LC and PGRP-LE have essential yet distinct functions in the drosophila immune response to monomeric DAP-type peptidoglycan. Nat Immunol 7:715-723
69. Karimova G, Fayolle C, Gmira S et al (1998) Charge-dependent translocation of Bordetella pertussis adenylate cyclase toxin into eukaryotic cells: implication for the in vivo delivery of CD8(+) T cell epitopes into antigen-presenting cells. Proc Natl Acad Sci USA 95:12532-12537
70. Kawai T, Akira S (2009) The roles of TLRs, RLRs and NLRs in pathogen recognition. Int Immunol 21:317-337
71. Khelef N, Gounon P, Guiso N (2001) Internalization of Bordetella pertussis adenylate cyclase-haemolysin into endocytic vesicles contributes to macrophage cytotoxicity. Cell Microbiol 3:721-730
72. Khelef N, Zychlinsky A, Guiso N (1993) Bordetella pertussis induces apoptosis in macrophages: role of adenylate cyclase-hemolysin. Infect Immun 61:4064-4071
73. Kirimanjeswara GS, Agosto LM, Kennett MJ et al (2005) Pertussis toxin inhibits neutrophil recruitment to delay antibody-mediated clearance of Bordetella pertussis. J Clin Invest 115:3594-3601
74. Kowalzik F, Barbosa AP, Fernandes VR et al (2007) Prospective multinational study of pertussis infection in hospitalized infants and their household contacts. Pediatr Infect Dis J 26:238-242
75. Ladant D, Ullmann A (1999) Bordetella pertussis adenylate cyclase: a toxin with multiple talents. Trends Microbiol 7:172-176
76. Leef M, Elkins KL, Barbic J et al (2000) Protective immunity to Bordetella pertussis requires both B cells and CD4(+) T cells for key functions other than specific antibody production. J Exp Med 191:1841-1852
77. Leininger E, Roberts M, Kenimer JG et al (1991) Pertactin, an Arg-Gly-Asp-containing Bordetella pertussis surface protein that promotes adherence to mammalian cells. Proc Natl Acad Sci USA 88:345-349
78. Leung AK, Robson WL, Davies HD (2007) Pertussis in adolescents. Adv Ther 24:353-361
79. Liew FY, McInnes IB (2002) The role of innate mediators in inflammatory response. Mol Immunol 38:887-890
80. Locht C, Antoine R (1995) A proposed mechanism of ADP-ribosylation catalyzed by the pertussis toxin subunit S1. Biochimie 77:333-340
81. Locht C, Berlin P, Menozzi FD et al (1993) The filamentous haemagglutinin, a multifaceted adhesin produced by virulent Bordetells spp. Mol Microbiol 9:653-660
82. Magalhaes JG, Philpott DJ, Nahori MA et al (2005) Murine Nod1 but not its human orthologue mediates innate immune detection of tracheal cytotoxin. EMBO Rep 6:1201-1207
83. Mangmool S, Kurose H (2011) G(i/o) Protein-dependent and -independent actions of pertussis toxin (PTX). Toxins 3:884-899
84. Mann PB, Wolfe D, Latz E et al (2005) Comparative Toll-like receptor 4-mediated innate host defense to Bordetella infection. Infect Immun 73:8144-8152
85. Mascart F, Verscheure V, Malfroot A et al (2003) Bordetella pertussis infection in 2-month-old infants promotes type I T cell responses. J Immunol 170:1504-1509
86. Mattoo S, Miller JF, Cotter PA (2000) Role of Bordetella bronchiseptica fimbriae in tracheal colonization and development of a humoral immune response. Infect Immun 68:2024-2033
87. Medical Research Council (1956) Vaccination against whooping cough: relation between protection in children and results of laboratory tests. Br Med J 2:454-462
88. McGuirk P, McCann C, Mills KH (2002) Pathogen-specific T regulatory 1 cells induced in the respiratory tract by a bacterial molecule that stimulates interleukin 10 production by dendritic cells: a novel strategy for evasion of protective T helper type 1 responses by Bordetella pertussis. J Exp Med 195:221-231
89. Mielcarek N, Debrie AS, Raze D et al (2006) Attenuated Bordetella pertussis: new live vaccines for intranasal immunisation. Vaccine 24(Suppl 2):54-55
90. Mikelova LK, Halperin SA, Scheifele D et al (2003) Predictors of death in infants hospitalized with pertussis: a case control study of 16 pertussis deaths in Canada. J Pediatr 143:576-581
91. Mills KH, Barnard A, Watkins J et al (1993) Cell-mediated immunity to Bordetella pertussis: role of Th1 cells in bacterial clearance in a murine respiratory infection model. Infect Immun 61:399-410
92. Mooi FR (2010) Bordetella pertussis and vaccination: the persistence of a genetic monomorphic pathogen. Infect Genet Evol 10:36-49
93. Mowen KA, Glimcher LH (2004) Signaling pathways in Th2 development. Immunol Rev 202:203-222
94. Nasso M, Fedele G, Spensieri F et al (2009) Genetically detoxified pertussis toxin induces Th1/Th17 immune response through MAPKs and IL-10-dependent mechanisms. J Immunol 183:1892-1899
95. Nishida M, Suda R, Nagamatsu Y et al (2010) Pertussis toxin up-regulates angiotensin type 1 receptor through Toll-like receptor 4-mediated Rac activation. J Biol Chem 285:15268-15277
96. O'Garra A, Robinson D (2004) Development and function of T helper 1 cells. Adv Immunol 83:133-162
97. Paccani SR, Dal Molin F, Benagiano M et al (2008) Suppression of T-lymphocyte activation and chemotaxis by the adenylate cyclase toxin of Bordetella pertussis. Infect Immun 76:2822-2832
98. Parton R, Hall E, Wardlaw AC (1994) Responses to Bordetella pertussis mutant strains and to vaccination in the coughing rat model of pertussis. J Med Microbiol 40:307-312
99. Perkins DJ, Gray MC, Hewlett EL et al (2007) Bordetella pertussis adenylate cyclase toxin (ACT) induces cyclooxygenase-2 (COX-2) in murine macrophages and is facilitated by ACT interaction with CD11b/CD18 (Mac-1). Mol Microbiol 66:1003-1015
100. Plaut RD, Carbonetti NH (2008) Retrograde transport of pertussis toxin in the mammalian cell. Cell Microbiol 10:1130-1139
101. Relman D, Tuomanen E, Falkow S et al (1990) Recognition of a bacterial adhesion by an integrin: macrophage CR3 (alpha M beta 2, CD11b/CD18) binds filamentous hemagglutinin of Bordetella pertussis. Cell 61:1375-1382
102. Ross PJ, Lavelle EC, Mills KH et al (2004) Adenylate cyclase toxin from Bordetella pertussis synergizes with lipopolysaccharide to promote innate interleukin-10 production and enhances the induction of Th2 and regulatory T cells. Infect Immun 72:1568-1579
103. Rossi Paccani S, Benagiano M, Capitani N et al (2009) The adenylate cyclase toxins of Bacillus anthracis and Bordetella pertussis promote Th2 cell development by shaping T cell antigen receptor signaling. PLoS Pathog 5:e1000325
104. Saukkonen K, Burnette WN, Mar VL et al (1992) Pertussis toxin has eukaryotic-like carbohydrate recognition domains. Proc Natl Acad Sci 89:118-122
105. Scarlato V, Prugnola A, Aricò B et al (1990) Positive transcriptional feedback at the bvg locus controls expression of virulence factors in Bordetella pertussis. Proc Natl Acad Sci USA 87:6753-6757
106. Schaeffer LM, McCormack FX, Wu H et al (2004) Bordetella pertussis lipopolysaccharide resists the bactericidal effects of pulmonary surfactant protein A. J Immunol 173:1959-1965
107. Schneider OD, Weiss AA, Miller WE (2007) Pertussis toxin utilizes proximal components of the T-cell receptor complex to initiate signal transduction events in T cells. Infect Immun 75:4040-4049
108. Serra DO, Conover MS, Arnal L et al (2011) FHA-mediated cell-substrate and cell-cell adhesions are critical for Bordetella pertussis biofilm formation on abiotic surfaces and in the mouse nose and the trachea. PLoS One 6:e28811
109. Sindt KA, Hewlett EL, Redpath GT et al (1994) Pertussis toxin activates platelets trough an interaction with platelet glycoprotein Ib. Infect Immun 62:3108-3114
110. Spensieri F, Fedele G, Fazio C et al (2006) Bordetella pertussis inhibition of interleukin-12 (IL-12) p70 in human monocyte-derived dendritic cells blocks IL-12 p35 through adenylate cyclase toxin-dependent cyclic AMP induction. Infect Immun 74:2831-2838
111. Stein PE, Boodhoo A, Armstrong GD et al (1994) The crystal structure of pertussis toxin. Structure 2:45-57
112. Stefanelli P, Fazio C, Fedele G et al (2009) A natural pertactin deficient strain of Bordetella pertussis shows improbe entry in human monocyte-derived dendritic cells. New Microbiol 32:159-166
113. Stenger RM, Smits M, Kuipers B et al (2010) Impaired long-term maintenance and function of Bordetella pertussis specific B cell memory. Vaccine 28:6637-6646
114. Storsaeter J, Hallander HO, Gustafsson L et al (1998) Levels of anti-pertussis antibodies related to protection after household exposure to Bordetella pertussis. Vaccine 16:1907-1916
115. Tasken K, Stokka AJ (2006) The molecular machinery for cAMP-dependent immunomodulation in T-cells. Biochem Soc Trans 34:476-479
116. + T lymphocytes. Eur J Immunol 36:1794-1804
117. Tonon S, Goriely S, Aksoy E et al (2002) Bordetella pertussis toxin induces the release of inflammatory cytokines and dendritic cell activation in whole blood: impaired response in human newborns. Eur J Immunol 32:3118-3125
118. Trinchieri G, Pflanz S, Kastelein RA (2003) The IL-12 family of heterodimeric cytokines: new players in the regulation of T cell responses. Immunity 19:641-644
119. Trollfors B, Lagergard T, Taranger J et al (2001) Serum immunoglobulin G antibody responses to Bordetella pertussis lipooligosaccharide and B. parapertussis lipopolysaccharide in children with pertussis and parapertussis. Clin Diagn Lab Immunol 8:1015-1017
120. Ulloa-Gutierrez R, Boza R, Carvajal-Riggioni D et al (2011) Pertussis: should we improve intensive care management or vaccination strategies? Expert Rev Vaccines 10:49-53
121. van de Berg BM, Beekhuizen H, Willems RJ et al (1999) Role of Bordetella pertussis virulence factors in adherence to epithelial cell lined derived from the human respiratory tract. Infect Immun 67:1056-1062
122. Veldhoen M, Hocking RJ, Atkins CJ et al (2006) TGFbeta in the context of an inflammatory cytokine milieu supports de novo differentiation of IL-17-producing T cells. Immunity 24:179-189
123. Verschueren H, Dewit J, Van der Wegen A et al (1991) The lymphocytosis promoting action of pertussis toxin can be mimicked in vitro. Holotoxin but not the B subunit inhibits invasion of human T lymphoma cells through fibroblast monolayers. J Immunol Methods 144:231-240
124. von Konig CH, Halperin S, Riffelmann M et al (2002) Pertussis of adults and infants. Lancet Infect Dis 2:744-750
125. Wang ZY, Yang D, Chen Q et al (2006) Induction of dendritic cell maturation by pertussis toxin and its B subunit differentially initiate Toll-like receptor 4-dependent signal transduction pathways. Exp Hematol 34:1115-1124
126. Ward JI, Cherry JD, Chang SJ et al (2006) Bordetella pertussis infections in vaccinated and unvaccinated adolescents and adults, as assessed in a national prospective randomized Acellular Pertussis Vaccine Trial (APERT). Clin Infect Dis 43:151-157
127. Weber MS, Benkhoucha M, Lehmann-Horn K et al (2010) Repetitive pertussis toxin promotes development of regulatory T cells and prevents central nervous system autoimmune disease. PLoS One 5:e16009
128. Xing DK, Canthaboo C, Corbel MJ (1998) Nitric oxide induction in murine macrophages and spleen cells by whole-cell Bordetella pertussis vaccine. Vaccine 16:16-23
129. Zheng Y, Rudensky AY (2007) Foxp3 in control of the regulatory T cell lineage. Nat Immunol 8:457-462